Event Brief
GLP-1 drugs linked to rare, potentially deadly brain disorder
By The BriefBrief · Sources (2)
Filed: Sep 13, 2026 at 2:07 PM ET
Summary: A University of California San Diego study published in Clinical Nutrition linked 15 reported cases of Wernicke encephalopathy to GLP-1 receptor agonists. The neurological disorder is caused by severe vitamin B1 deficiency, and most cases involved semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro/Zepbound).
WHO: University of California San Diego researchers
WHAT: Study linked GLP-1 receptor agonists to reported cases of Wernicke encephalopathy caused by severe vitamin B1 deficiency.
WHEN: Sep 13, 2026 at 1:00 PM ET
WHERE: Location not specified
WHY: Cause not yet established.
В России начнут следить за ценами на 24 продукта
Правительство России
Sep 13, 2026 at 2:07 PM ET
Минная ловушка для ВСУ: боевики подорвались при побеге
Всу
Sep 13, 2026 at 2:07 PM ET
Россия может снизить или обнулить сбор за визы
Россия
Sep 13, 2026 at 2:07 PM ET
Antonelli wins Spanish Grand Prix as Norris misses out
F1
Sep 13, 2026 at 2:07 PM ET
